
Currently out of the existing stock ratings of Ling Wang, 35 are a BUY (100%).
Analyst Ling Wang, currently employed at JPMORGAN, has had 46.46% of price targets met with an average potential upside of 45.52%, reached in 446 days on average. Previously, Ling Wang worked at BTIG, OPPENHEIMER, CHARDAN CAPITAL.
Ling Wang has documented 79 price targets and ratings displayed on 12 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on DQ, Daqo New Energy Corp ADR at 24-Sep-2021.
Analyst best performing recommendations are on LJPC (LA JOLLA PHARMACEUTICAL CO).
The best stock recommendation documented was for LJPC (LA JOLLA PHARMACEUTICAL CO) on 4/20/2015. The price target of $43 was fulfilled within 141 days with a profit of $23.93 (125.49%), with a performance score of 8.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Feb-2024
$31
$31
2 years 9 months 5 days ago
(12-Feb-2024)
5/6 (83.33%)
$-0.23 (-0.74%)
121
Buy Since 04-Dec-2023
$31
$31
2 years 11 months 13 days ago
(04-Dec-2023)
9/9 (100%)
$1.78 (6.09%)
417
Buy Since 16-Nov-2022
$31
$26
2 years 11 months 16 days ago
(01-Dec-2023)
4/4 (100%)
$1.68 (5.73%)
114
Buy Since 01-Dec-2023
$31
$12
2 years 11 months 16 days ago
(01-Dec-2023)
2/2 (100%)
$1.68 (5.73%)
294
Buy Since 01-Dec-2023
$31
2 years 11 months 16 days ago
(01-Dec-2023)
6/6 (100%)
$1.68 (5.73%)
565
What Year was the first public recommendation made by Ling Wang?